Massachusetts General Hospital, Boston, MA, USA; Department of Genetics, Harvard
Medical School, Boston, MA, USA
HEENA JAGATIA • Department of Respiratory Sciences, University of Leicester, Leicester, UK
BENJAMIN K. JOHNSON • Department of Microbiology and Molecular Genetics, Michigan
State University, East Lansing, MI, USA
EACHAN O. JOHNSON • The Francis Crick Institute, London, UK
RICHARD M. JONES JR. • Department of Microbiology, University of Washington, Seattle,
WA, USA
POOJA KESHAVAN • Division of Translational Medicine, Wadsworth Center, New York State
Department of Health, Albany, NY, USA
STEPHEN P. KING • ATCC, Manassas, VA, USA
PHILLIP KNABENBAUR • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology & Pathology, Colorado State University, Fort Collins, CO, USA
RAVI K. KORIPELLA • Division of Translational Medicine, Wadsworth Center, New York State
Department of Health, Albany, NY, USA
NICOLE A. KRUH-GARCIA • Mycobacteria Research Laboratories, Department of
Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO,
USA; BioMARC, Colorado State University, Fort Collins, CO, USA
RAMANUJ LAHIRI • United States Department of Health and Human Services, Health
Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s
Disease Program, Baton Rouge, LA, USA
MARIE-ANTOINETTE LANE ´ ELLE • Tuberculosis & Infection Biology Department, Institut de
Pharmacologie et de Biologie Structurale (IPBS), Centre National de la Recherche
Scientifique (CNRS), Toulouse, France; Universite ´ de Toulouse, Universite ´ Paul Sabatier
(Toulouse III), Toulouse, France
EMILIE LAYRE • Institut de Pharmacologie et de Biologie Structurale, Universite ´ de Toulouse,
CNRS, Universite ´ Paul Sabatier, Toulouse, France
LOUISE H. LEFRANC ¸ OIS • Department of Biochemistry, Faculty of Science, University of
Geneva, Geneva, Switzerland
ANNE LEMASSU • Tuberculosis & Infection Biology Department, Institut de Pharmacologie et
de Biologie Structurale (IPBS), Centre National de la Recherche Scientifique (CNRS),
Toulouse, France; Universite ´ de Toulouse, Universite ´ Paul Sabatier (Toulouse III), Toulouse,
France
YUNLONG LI • Division of Genetics, Wadsworth Center, New York State Department of
Health, Albany, NY, USA
MEGAN LUCAS • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
SHUYI MA • Department of Microbiology, University of Washington, Seattle, WA, USA
ARNAUD MACHELART • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille,
Center for Infection and Immunity of Lille (CIIL), Lille Cedex, France
GIULIA MANINA • Microbial Individuality and Infection Group, Cell Biology and Infection
Department, Microbiology Department, Institut Pasteur, Paris, France
M. CARLA MARTINI • Department of Biology & Biotechnology, Worcester Polytechnic Institute,
Worcester, MA, USA
A. BRETT MASON • Center for Discovery and Innovation, Hackensack Meridian Health,
Nutley, NJ, USA
CONOR J. MEEHAN • University of Bradford, Bradford, UK
Contributors
xiii
Précédent

- 13/734

Suivant